Trailblazing cancer scientist leaves lasting legacy

The death of distinguished cancer biologist Dr. Juliet Michelle Daniel on Tuesday, April 27^th, 2026, has been felt far beyond her family and close circle. A pioneering scientist, mentor, and advocate, Dr. Daniel leaves behind a legacy that reshaped cancer research and challenged the systems surrounding it.

Born in Barbados to Lionel and Juliet Daniel, she attended Queen’s College before pursuing higher education in Canada. She earned her Bachelor of Science from Queen’s University and completed her PhD in Molecular Biology at the University of British Columbia. Her postdoctoral training included work at St. Jude Children’s Research Hospital and Vanderbilt University in Tennessee, early signals of a career that would bridge rigorous science with human impact.

In 1999, Dr. Daniel joined McMaster University’s Department of Biology as an associate professor, later serving as Associate Dean of Research and External Relations in the Faculty of Science. Her career was shaped by intellectual pursuit and by personal loss. The death of her mother from ovarian cancer when Dr. Daniel was just 21, along with the loss of other relatives, profoundly influenced her decision to enter cancer research.

Her work focused on aggressive cancers, particularly triple-negative breast cancer (TNBC), which disproportionately affects Black women. She was not content with discovery alone. As noted in a tribute, “She insisted that cancer biology could not be separated from health equity.” That belief defined her work. She became a powerful voice advocating that scientific breakthroughs must reach the communities they are meant to serve.

Dr. Daniel also supported community-based organizations, including The Olive Branch of Hope (TOBOH), which centers Black women navigating breast cancer. Her involvement in the GenCARE project at McMaster reflected her commitment to studying TNBC in women of African ancestry, an area historically underfunded and under-researched. She attended TOBOH’s “Legacy of Hope Gala; Celebrating 25 Years Together” on April 11^th, 2026, in Toronto, an event described as a celebration of sisterhood, resilience and community.

Tributes have poured in from across sectors. Mia Amor Mottley, Prime Minister of Barbados, remembered her as both a friend and a national icon: a scientist whose discovery of the Kaiso gene carried her brilliance and her Caribbean identity into the international scientific community. The naming of the gene itself (rooted in Caribbean culture) symbolized Dr. Daniel’s commitment to representation within scientific spaces.

The Consulate General of Barbados described her as an esteemed biologist, professor, and proud Barbadian Canadian. Lydia-Joi Marshall, President of the Black Health Alliance, emphasized Dr. Daniel’s advocacy and mentorship: “The way that she unapologetically mentored Black students and demanded excellence was both a reflection of her Barbadian training and personal ethics.”

Her accolades were numerous, including the Ontario Premier’s Research Excellence Award, the African Canadian Achievement Award in Science, the Harry Jerome Innovation & Technology Award, and WXN Canada’s Top 100 Most Powerful Women designation. Yet her influence extended beyond awards. As co-founder of the Canadian Black Scientists Network, she helped build pathways for Black scholars in STEMM, ensuring visibility, connection, and opportunity.

Dr. Daniel also championed equitable research funding, particularly for women’s health. She consistently challenged gaps in who benefits from scientific progress, pushing for inclusion not just in participation, but in outcomes.

She passed away peacefully, surrounded by family, following a stroke.

A Celebration of Life will be held on Saturday, May 30^th at 10:30 a.m. at Heartland Church in Mississauga. A virtual Book of Remembrance is also available for those wishing to share reflections.

Dr. Juliet Daniel’s life was about who discovery serves. In that, her legacy is both scientific and deeply human.